Search results for: 'deep fund'

As digitization progresses across industries, AI is gaining a ubiquitous adoption as more and more business processes are being automated. With this, the expectations from AI in terms of what applications can be realized using AI is also expanding, and thus a more complex set of neural networks have been introduced which are expected to leverage ad...

In this research service, Frost & Sullivan presents the US Department of Homeland Security (DHS) Coast Guard (USCG) fiscal year (FY) 2025 spending request, outlining the budget categories, key spending priorities, ongoing acquisition programs, and significant contracts. In addition, the study highlights the key growth-driving and restraining fac...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers provides strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision therapeutics. It highlights advances in AI-enabled diagnostics, metabolic reprogramming, small molecules, deep proteomics, RNA disco...

The rising demand for faster and more secure transactions along with full transparency has made blockchain one of the fastest growing technology markets in the world. Banks and technology providers are investing heavily in R&D activity related to verifying and recording finance transactions. Also, major US technology companies such as IBM, Microsof...

Mitigating greenhouse gases is the way ahead to avert catastrophes arising from climate change. Permanently removing greenhouse gas emissions from the atmosphere is a huge and urgent task. Emission reduction technologies are necessary to achieve deep decarbonization in emission-intensive industries and net-zero emissions in the long term. Industry ...

Frost & Sullivan hosted a number of top-end-user companies across various industries, including retail, finance, healthcare, and automotive, as well as solution providers and consulting thought leaders. The audience was consistently engaged in highly energized discussions, sharing challenges and best practices to enhance their contact centers and a...

A major challenge in drug discovery is the limited number of gene targets that can be targeted for the development of a drug molecule. Only close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unexplored as targets, and some are considered undruggable. The identification and the selection of novel drug targets (p...

It is difficult to understand what is happening in the field of artificial intelligence (AI). New developments seem to happen weekly, and companies use different words to describe their products. The terms artificial intelligence, cognitive intelligence, autonomous machines, and machine learning are all thrown around. This research brings clarity t...

In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects. ...